Nestl Health Science increases stake in Aimmune Therapeutics

Nestlé Health Science increases stake in Aimmune Therapeutics

03:13 EST 13 Nov 2018 | Pharmaceutical Business Review

Aimmune Therapeutics is engaged in the development of advanced treatments for life-threatening food allergies. The latest investment brings Nestlé’s total investment in the drug developer for food allergies

The post Nestlé Health Science increases stake in Aimmune Therapeutics appeared first on Pharma Business review.

Original Article: Nestlé Health Science increases stake in Aimmune Therapeutics

More From BioPortfolio on "Nestlé Health Science increases stake in Aimmune Therapeutics"